Biovac Vaccine Tender Secures Critical R5.3bn State Contract Biovac vaccine tender secures a vital R5.3bn state contract for Hexaxim, driving Africa’s local manufacturing goals. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
